Abstract: The present disclosure relates to a pre-5th-Generation (5G) or 5G communication system to be provided for supporting higher data rates Beyond 4th-Generation (4G) communication system such as Long Term Evolution (LTE). According to various embodiments of the present disclosure, a method for operating a receiving device in a wireless communication system is provided. The method includes receiving a signal from a transmitting device which includes a plurality of transmit antennas, determining, based on the signal, multiple symbol vectors from symbol vectors possibly transmitted from a first transmit antenna and a second transmit antenna of the plurality of transmit antennas, and determining combinations of symbols transmitted from the first transmit antenna and the second transmit antenna by searching, for each of the multiple symbol vectors, at least one other symbol vector within a first preset distance from each of the multiple symbol vectors.

Abstract: A data driver includes a digital to analog converter configured to receive a reference gray voltage and image data, and configured to generate gray voltages corresponding to the image data, and an output buffer including a plurality of buffer circuits connected to an output terminal of the digital to analog converter, and configured to selectively receive one of the gray voltages.

Abstract: Improved methods of synthesizing oxygen-functionalized boron nitride (O—BN) are disclosed. In the disclosed methods, boron nitride (BN) in any form is contacted with a gaseous composition or compositions that include oxygen and an organic compound, such as, but not limited to, a hydrocarbon.

Abstract: Provided is a method for increasing the lifetime of devices of a cluster-tree structured multi-hop wireless communication system which uses a battery as the main power and includes an access point (AP) managing network operation and a plurality of devices connected to the AP, wherein some network devices operates as a router capable of having its child devices, the rest of the network device operate as an end device incapable of having its child devices, and the AP, the routers, and the end devices are connected in a parent-child device relationship. The method includes equalizing the average power consumption of each device by exchanging the roles of the router and the end device requiring different power consumption without interrupting normal network operation.

Abstract: Provided is a cancer cell growth inhibition and killing device using a blue light LED. The present invention comprises: a bed part which has a top plate on which the body is laid to stand by; a main body part provided with a treatment space, which has a predetermined size and on which the bed part is disposed, and having a chamber which is divided by the treatment space and a transparent plate formed of a light-transmitting material to thus form a treatment light generation space; and a treatment light generation unit which generates a treatment light having a wavelength band of a predetermined size when power is applied so that the treatment light can penetrate the subcutaneous tissue of the body and thereby stimulate and kill cancer cells moving along blood vessels, and which is provided in the chamber so as to irradiate the treatment space with the treatment light after the treatment light has penetrated though the transparent plate.

Abstract: Disclosed herein are bicyclic peptide compounds, compositions comprising same, methods for making same, and libraries comprising same. The disclosed compounds, in various aspects, are useful for treating a variety of disorders, including inflammatory disorders, autoimmune disorders, and disorders of uncontrolled cellular proliferation. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: A resistive random access memory (Device) is disclosed. The Device includes a substrate, a first electrode formed atop the substrate, a tunneling barrier layer formed atop the first electrode, an active material formed atop the tunneling barrier layer, an isolation layer formed atop the active material, and a second electrode formed atop the isolation layer, the first electrode and the second electrode provide electrical connectivity to external components, where the active material is a phase change material which undergoes phase transition in the presence of an electric field, Joule heating, or a combination thereof.

Abstract: An associative processor separates the arithmetic operation of addition from the carry process to pre-compute contingent carries before the addition which then allows improved parallelism in the addition process. A portion of the contingent carry computation may also be conducted in parallel. The result is higher-speed operations resulting from increased parallelism.

Abstract: Immunogenic compositions and methods of using them include a biodegradable or bioerodible polyanhydride nanoparticle comprising 1,8-bis(p-carboxyphenoxy)-3,6-dioxaoctane (CPTEG) and 1,6-bis(p-carboxyphenoxy)hexane (CPH) copolymers, an immunogenic protein of an Influenza Virus and an adjuvant entrapped within an interior of the nanoparticle, and an excipient. The immunogenic composition may be administered to a subject to confer both local and systemic immunity to the Influenza Virus.

Abstract: Systems, methods, and computer program product embodiments are disclosed for displaying cardiac signals based on a signal pattern. An embodiment operates by accessing an input cardiac signal. The embodiment matches a portion of the input cardiac signal to a known signal pattern. The embodiment then displays an indication of a degree of the match.

Abstract: Compositions are provided that comprise a microvesicle derived from an edible plant. The microvesicles are coated with a plasma membrane derived from a targeting cell and can further be utilized to encapsulate a therapeutic agent. Methods for treating an inflammatory disorder and/or a cancer are further provided and include the step of administering to a subject an effective amount of a composition that includes a microvesicle coated with a plasma membrane derived from a targeting cell.

Abstract: Provided are a transmitting device connected to a receiving device via a channel and the receiving device connected to the transmitting device via a channel. The transmitting device connected to a receiving device includes: a transmitter connected to the channel via an output node and configured to transmit, via the channel, a transmission signal to the receiving device, the transmitter having a transmission impedance associated therewith that is variable; and a monitoring device configured to detect a channel impedance of the channel and a receiving impedance of the receiving device by monitoring a voltage level of the output node, the monitoring device configured to set the transmission impedance based on the channel impedance and the receiving impedance.

Abstract: Disclosed are an apparatus and a method for gait type classification using a pressure sensor of a smart insole, which are capable of classifying pieces of gait data having various variances using only a pressure sensor. The apparatus for gait type classification includes a gait data measuring part configured to measure pieces of gait data using a pressure sensor, a pre-processor configured to define a section of a unit step in all the pieces of gait data, divide the pieces of gait data for each unit step, and normalize the pieces of divided gait data to equalize lengths of the pieces of divided gait data, and a feature extractor configured to extract features suitable for gait type classification from the pieces of pre-processed gait data, and a gait type classifier configured to receive the extracted features as an input and determine and classify a final gait type.

Abstract: This document provides methods and materials involved in treating cancer. For example, methods and materials for using an inhibitor of UFM1 activity or expression and/or an inhibitor of UFL1 activity or expression to reduce a cancer cell's ability to carry out a DDR, thereby increasing the sensitivity of cancer cells to treatment with a DNA damaging therapy such as radiation or chemotherapy, are provided.

Abstract: A method of depositing a multiphase material. The method includes providing a Continuous Multifunctional Composite (CMC) phase containing at least one continuous element in a polymeric matrix, passing the CMC phase through a feeding system containing a cutting system, producing a predetermined length of the CMC phase, providing a flow a molten polymer such that the molten polymer and the CMC phase are merged into a continuous co-extrusion nozzle so as to produce a co-extruded multiphase material, and depositing the co-extruded multiphase material onto a surface. An apparatus for depositing a multiphase material. The apparatus contains a co-extrusion nozzle, a means to introduce a CMC phase and a molten polymer into the co-extrusion nozzle, such that the molten polymer and the CMC phase are co-extruded and deposited on a surface. An article containing a CMC phase containing continuous elements embedded in a polymer resin forming a multiphase structure.

Abstract: A system and method are provided for non-invasively assessing neuro-inflammation in a subject. The method includes acquiring neurite orientation dispersion and density imaging (NODDI) data of the subject and processing the NODDI data to determine an orientation dispersion index (ODI) component of the NODDI data. The method also includes assessing the ODI component against one of a reference of neuro-inflammation or a prior ODI component acquired from the subject to determine one of an acute assessment or a chronic assessment of neuro-inflammation in the subject. The method further includes generating a report indicating the one of an acute assessment or a chronic assessment of neuro-inflammation in the subject.

Abstract: This document provides antibodies against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) short, and more particularly to humanized TRAILshort antibodies that can neutralize TRAILshort. For example, materials and methods for using one or more humanized TRAILshort antibodies to induce apoptosis (e.g., via TRAIL mediated cell death, natural killer (NK) cytotoxicity, and/or CD8+ T cell killing) are provided.

Abstract: A molecular kinetics evaluation method is provided which involves: a step for dosing a human or non-human animal with a proteolysis-inducing molecule, which is a conjugate of a proteolysis induction tag, i.e., a molecule which has affinity for protease and which does not inhibit proteolysis by protease, and a specific protein affinity molecule having affinity to a specific protein, and inducing proteolysis of the specific protein in vivo in the human or non-human animal; and a step for evaluating the molecular kinetics of the specific protein affinity molecules or the proteolysis-inducing molecules by detecting proteolysis of the specific proteins in a sample which is at least part of the human or non-human animal.

Abstract: A method of determining stress within a composite structure is provided which includes coupling a sensor to a composite structure under load having embedded therein a plurality of particles, wherein the particles at room temperature are paraelectric or ferroelectric, transmitting an electromagnetic radiation to the sensor, thereby generating an electromagnetic field into the composite structure, sweeping frequency from a first frequency to a second frequency in a pulsed manner, receiving reflected power from the composite structure, determining the resonance frequency of the sensor, and translating the resonance frequency of the sensor to stress within the composite structure.

Abstract: An object of the present invention is to provide an organic electroluminescent element having optimal light emitting characteristics. The above problem is solved by an organic electroluminescent element having a light emitting layer containing a compound of formula (1) or a multimer compound having a plurality of structures of formula (1) and a compound of formula (2). (In formula (1), ring A, ring B, and ring C each represent an aryl ring or the like, X1 and X2 each independently represent O or N—R, and the R represents an aryl or the like. In formula (2), R1 to R16 each represent an aryl or the like.